These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1518 related items for PubMed ID: 25656808

  • 1. Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature.
    Fütterer JJ, Briganti A, De Visschere P, Emberton M, Giannarini G, Kirkham A, Taneja SS, Thoeny H, Villeirs G, Villers A.
    Eur Urol; 2015 Dec; 68(6):1045-53. PubMed ID: 25656808
    [Abstract] [Full Text] [Related]

  • 2. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.
    Moldovan PC, Van den Broeck T, Sylvester R, Marconi L, Bellmunt J, van den Bergh RCN, Bolla M, Briers E, Cumberbatch MG, Fossati N, Gross T, Henry AM, Joniau S, van der Kwast TH, Matveev VB, van der Poel HG, De Santis M, Schoots IG, Wiegel T, Yuan CY, Cornford P, Mottet N, Lam TB, Rouvière O.
    Eur Urol; 2017 Aug; 72(2):250-266. PubMed ID: 28336078
    [Abstract] [Full Text] [Related]

  • 3. Negative Multiparametric Magnetic Resonance Imaging for Prostate Cancer: What's Next?
    Panebianco V, Barchetti G, Simone G, Del Monte M, Ciardi A, Grompone MD, Campa R, Indino EL, Barchetti F, Sciarra A, Leonardo C, Gallucci M, Catalano C.
    Eur Urol; 2018 Jul; 74(1):48-54. PubMed ID: 29566957
    [Abstract] [Full Text] [Related]

  • 4. Detection of Gleason 6 prostate cancer in patients with clinically significant prostate cancer on multiparametric magnetic resonance imaging.
    Chaloupka M, Bischoff R, Pfitzinger P, Lellig E, Ledderose S, Buchner A, Schlenker B, Stief C, Clevert DA, Apfelbeck M.
    Clin Hemorheol Microcirc; 2019 Jul; 73(1):105-111. PubMed ID: 31561351
    [Abstract] [Full Text] [Related]

  • 5. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
    Pokorny MR, de Rooij M, Duncan E, Schröder FH, Parkinson R, Barentsz JO, Thompson LC.
    Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
    [Abstract] [Full Text] [Related]

  • 6. Can 3-Tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA < 10 ng/mL?
    Pepe P, Garufi A, Priolo G, Pennisi M.
    Clin Genitourin Cancer; 2015 Feb; 13(1):e27-30. PubMed ID: 25081324
    [Abstract] [Full Text] [Related]

  • 7. Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy.
    Pepe P, Cimino S, Garufi A, Priolo G, Russo GI, Giardina R, Reale G, Pennisi M, Morgia G.
    Scand J Urol; 2017 Aug; 51(4):260-263. PubMed ID: 28513296
    [Abstract] [Full Text] [Related]

  • 8. Magnetic resonance imaging in prostate cancer detection and management: a systematic review.
    Monni F, Fontanella P, Grasso A, Wiklund P, Ou YC, Randazzo M, Rocco B, Montanari E, Bianchi G.
    Minerva Urol Nefrol; 2017 Dec; 69(6):567-578. PubMed ID: 28488844
    [Abstract] [Full Text] [Related]

  • 9. Prebiopsy multiparametric MRI-based risk score for predicting prostate cancer in biopsy-naive men with prostate-specific antigen between 4-10 ng/mL.
    Dwivedi DK, Kumar R, Dwivedi AK, Bora GS, Thulkar S, Sharma S, Gupta SD, Jagannathan NR.
    J Magn Reson Imaging; 2018 May; 47(5):1227-1236. PubMed ID: 28872226
    [Abstract] [Full Text] [Related]

  • 10. Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy.
    Jambor I, Kähkönen E, Taimen P, Merisaari H, Saunavaara J, Alanen K, Obsitnik B, Minn H, Lehotska V, Aronen HJ.
    J Magn Reson Imaging; 2015 May; 41(5):1394-404. PubMed ID: 24956412
    [Abstract] [Full Text] [Related]

  • 11. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L.
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [Abstract] [Full Text] [Related]

  • 12. A prospective study investigating the impact of multiparametric MRI in biopsy-naïve patients with clinically suspected prostate cancer: The PROKOMB study.
    Baur ADJ, Henkel T, Johannsen M, Speck T, Weißbach L, Hamm B, König F.
    Contemp Clin Trials; 2017 May; 56():46-51. PubMed ID: 28279782
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer.
    Panebianco V, Valerio MC, Giuliani A, Pecoraro M, Ceravolo I, Barchetti G, Catalano C, Padhani AR.
    Eur Urol Oncol; 2018 Aug; 1(3):208-214. PubMed ID: 31102623
    [Abstract] [Full Text] [Related]

  • 15. Accuracy of 3 Tesla pelvic phased-array multiparametric MRI in diagnosing prostate cancer at repeat biopsy.
    Pepe P, Garufi A, Priolo G, Dibenedetto G, Salemi M, Pennisi M, Fraggetta F, Aragona F, Barbera M.
    Arch Ital Urol Androl; 2014 Dec 30; 86(4):336-9. PubMed ID: 25641466
    [Abstract] [Full Text] [Related]

  • 16. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience.
    Costa DN, Kay FU, Pedrosa I, Kolski L, Lotan Y, Roehrborn CG, Hornberger B, Xi Y, Francis F, Rofsky NM.
    Urol Oncol; 2017 Apr 30; 35(4):149.e15-149.e21. PubMed ID: 27939349
    [Abstract] [Full Text] [Related]

  • 17. Multiparametric MRI in men with clinical suspicion of prostate cancer undergoing repeat biopsy: a prospective comparison with clinical findings and histopathology.
    Boesen L, Nørgaard N, Løgager V, Balslev I, Thomsen HS.
    Acta Radiol; 2018 Mar 30; 59(3):371-380. PubMed ID: 28679325
    [Abstract] [Full Text] [Related]

  • 18. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
    Radtke JP, Schwab C, Wolf MB, Freitag MT, Alt CD, Kesch C, Popeneciu IV, Huettenbrink C, Gasch C, Klein T, Bonekamp D, Duensing S, Roth W, Schueler S, Stock C, Schlemmer HP, Roethke M, Hohenfellner M, Hadaschik BA.
    Eur Urol; 2016 Nov 30; 70(5):846-853. PubMed ID: 26810346
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preliminary Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Focal Therapy with Irreversible Electroporation.
    Scheltema MJ, Chang JI, van den Bos W, Böhm M, Delprado W, Gielchinsky I, de Reijke TM, de la Rosette JJ, Siriwardana AR, Shnier R, Stricker PD.
    Eur Urol Focus; 2019 Jul 30; 5(4):585-591. PubMed ID: 29102671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 76.